Barington Companies Management LLC Purchases Shares of 125,000 Bath & Body Works, Inc. $BBWI

Key Points

• Barington Companies Management LLC purchased 125,000 shares of Bath & Body Works (≈$3.22M) in Q3, making BBWI its 10th‑largest holding at 2.4% of the fund and about 0.06% of the company.
• Bath & Body Works beat Q4 estimates (EPS $2.05 vs. $1.77) and issued FY2026 guidance of $2.40–$2.65, while also declaring a $0.20 quarterly dividend (≈3.8% yield).
• Shares trade near $20.85 with a MarketBeat consensus "Hold" target of $24, and the company faces near‑term legal risk from multiple securities class‑action filings despite mixed analyst optimism.

Barington Companies Management LLC bought a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 125,000 shares of the company's stock, valued at approximately $3,220,000. Bath & Body Works comprises 2.4% of Barington Companies Management LLC's investment portfolio, making the stock its 10th biggest holding. Barington Companies Management LLC owned approximately 0.06% of Bath & Body Works at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in BBWI. Grantham Mayo Van Otterloo & Co. LLC lifted its position in shares of Bath & Body Works by 26.4% during the 3rd quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 65,185 shares of the company's stock worth $1,679,000 after buying an additional 13,612 shares during the last quarter. First Trust Advisors LP raised its stake in Bath & Body Works by 8.6% during the 3rd quarter. First Trust Advisors LP now owns 257,927 shares of the company's stock worth $6,644,000 after acquiring an additional 20,316 shares in the last quarter. Neo Ivy Capital Management purchased a new stake in Bath & Body Works in the third quarter valued at $201,000. Gabelli Funds LLC lifted its position in Bath & Body Works by 1.2% in the third quarter. Gabelli Funds LLC now owns 47,536 shares of the company's stock valued at $1,225,000 after acquiring an additional 542 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in Bath & Body Works by 7.0% in the third quarter. Dimensional Fund Advisors LP now owns 2,574,082 shares of the company's stock valued at $66,311,000 after acquiring an additional 168,112 shares in the last quarter. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Trading Down 6.5%

NYSE:BBWI opened at $20.85 on Friday. The firm has a market cap of $4.27 billion, a P/E ratio of 6.62, a PEG ratio of 2.11 and a beta of 1.48. The stock's 50 day simple moving average is $22.39 and its 200-day simple moving average is $23.47. Bath & Body Works, Inc. has a 12-month low of $14.27 and a 12-month high of $34.66.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings results on Wednesday, March 4th. The company reported $2.05 earnings per share for the quarter, topping the consensus estimate of $1.77 by $0.28. Bath & Body Works had a negative return on equity of 45.60% and a net margin of 8.90%.The firm had revenue of $2.72 billion during the quarter, compared to the consensus estimate of $2.59 billion. During the same period last year, the company earned $2.09 earnings per share. The company's revenue for the quarter was down 2.3% on a year-over-year basis. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Research analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 6th. Stockholders of record on Friday, February 20th were paid a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.8%. The ex-dividend date was Friday, February 20th. Bath & Body Works's payout ratio is 25.40%.

Wall Street Analysts Forecast Growth

BBWI has been the topic of several research reports. Bank of America set a $26.00 price objective on Bath & Body Works in a report on Monday, November 24th. Barclays upped their target price on Bath & Body Works from $20.00 to $21.00 and gave the company an "equal weight" rating in a research report on Monday, March 2nd. Weiss Ratings restated a "hold (c-)" rating on shares of Bath & Body Works in a research note on Wednesday, January 21st. Citigroup cut Bath & Body Works from a "buy" rating to a "neutral" rating and boosted their price objective for the company from $21.00 to $25.00 in a research note on Tuesday, February 17th. Finally, Morgan Stanley reissued an "equal weight" rating and issued a $18.00 price objective (down from $43.00) on shares of Bath & Body Works in a report on Friday, November 21st. Three equities research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the stock. Based on data from MarketBeat, Bath & Body Works presently has a consensus rating of "Hold" and a consensus target price of $24.00.

Bath & Body Works News Summary

Here are the key news stories impacting Bath & Body Works this week:

• Positive Sentiment: Company beat Q4 EPS and revenue expectations and outlined a Consumer First growth plan that management says will drive longer‑term improvement. BBWI Beats on Q4 Earnings, Unveils Growth Strategy Amid Soft Demand
• Positive Sentiment: Several analysts raised forecasts and price targets after the quarter (examples: Telsey upped to $25, Deutsche Bank to $22), providing support for upside vs. recent levels. These Analysts Raise Their Forecasts On Bath & Body Works Following Q4 Results
• Positive Sentiment: Several bullish commentary pieces framed BBWI as a deep‑value / turnaround opportunity following the quarter. Bath & Body Works: A Deep Value Opportunity That's Too Cheap To Ignore
• Neutral Sentiment: Barclays maintained a hold rating (no upgrade), reflecting mixed analyst views on near‑term demand even after the beat. Barclays Sticks to Their Hold Rating for Bath & Body Works (BBWI)
• Neutral Sentiment: Management says the strategic shift is making progress but “will take time,” a cautious tone that tempers the immediate impact of the earnings beat. Bath & Body Works Says Strategy Shift Making Progress But ‘Will Take Time’
• Negative Sentiment: Multiple law firms have filed or are soliciting lead‑plaintiff applicants in a securities class action covering June 4, 2024–Nov 19, 2025, with lead‑plaintiff deadlines in mid‑March — these recurring headlines raise near‑term legal and reputational risk that can pressure the stock. Representative notices: BBWI FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL... The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline... BBWI Investors Have Opportunity to Lead Bath & Body Works Inc Securities Fraud Lawsuit...

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.